Yatin R Gokarn

Title: Yatin R Gokarn: Innovator in Self-Buffering Antibody Formulations

Introduction

Yatin R Gokarn is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly with his innovative work on self-buffering protein formulations. His research focuses on creating formulations that are beneficial for both veterinary and human medical use.

Latest Patents

Yatin R Gokarn holds 1 patent for his invention titled "Self-buffering antibody formulations." This invention provides self-buffering pharmaceutical protein formulations that are substantially free of other buffering agents. The formulations are designed to stably maintain pH over extended periods, which is crucial for the distribution and storage of pharmaceutical proteins. The invention also outlines methods for designing, making, and using these formulations, which can be applied to a wide variety of proteins.

Career Highlights

Yatin R Gokarn is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to contribute to advancements in medical treatments through innovative protein formulations. His research is particularly valuable for the treatment of diseases in human subjects.

Collaborations

Yatin has collaborated with notable coworkers such as Eva Kras and Richard L Remmele, Jr. These collaborations have further enhanced the development and application of his innovative formulations.

Conclusion

Yatin R Gokarn's contributions to the field of pharmaceutical formulations through his self-buffering antibody formulations represent a significant advancement in medical science. His work continues to impact the treatment of diseases, showcasing the importance of innovation in healthcare.